Revlimid and Atelectasis - a phase IV clinical study of FDA data
Atelectasis is found among people who take Revlimid, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Revlimid and have Atelectasis. It is created by eHealthMe based on reports of 331,128 people who have side effects when taking Revlimid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
331,128 people reported to have side effects when taking Revlimid.
Among them, 468 people (0.14%) have Atelectasis.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 331,426 Revlimid users for its effectiveness, alternative drugs and more.
What is Atelectasis?
Atelectasis (partial or complete collapse of the lung) is found to be associated with 2,369 drugs and 1,552 conditions by eHealthMe.
Number of Revlimid and Atelectasis reports submitted per year:
Time on Revlimid when people have Atelectasis *:
Gender of people who have Atelectasis when taking Revlimid*:
Age of people who have Atelectasis when taking Revlimid *:
Common drugs people take besides Revlimid *:
Common side effects people have besides Atelectasis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Revlimid and have Atelectasis?Check whether Atelectasis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Atelectasis and when was it recovered:
Expand to all the drugs that have ingredients of lenalidomide:
Alternative drugs to, pros and cons of Revlimid:
- Revlimid (331,426 reports)
Common Revlimid side effects:
- Death: 24,344 reports
- Diarrhea: 23,781 reports
- Fatigue (feeling of tiredness): 21,089 reports
- Multiple myeloma (cancer of the plasma cells): 17,070 reports
- Pneumonia: 16,950 reports
- Rashes (redness): 15,559 reports
- Thrombocytopenia (decrease of platelets in blood): 14,033 reports
- Weakness: 9,637 reports
Browse all side effects of Revlimid:a b c d e f g h i j k l m n o p q r s t u v w x y z
Atelectasis treatments and more:
- Atelectasis (15,967 reports)
COVID vaccines that are related to Atelectasis:
- Atelectasis in Moderna COVID Vaccine
- Atelectasis in Pfizer BioNTech Covid Vaccine
- Atelectasis in Johnson and Johnson Covid Vaccine
Common drugs associated with Atelectasis:
- Zometa: 2,329 reports
- Prednisone: 2,245 reports
- Aspirin: 1,825 reports
- Aredia: 1,509 reports
- Lasix: 1,440 reports
- Fosamax: 1,081 reports
- Lisinopril: 1,068 reports
- Coumadin: 1,049 reports
- Protonix: 968 reports
- Dexamethasone: 963 reports
All the drugs that are associated with Atelectasis:
- Atelectasis (2,369 drugs)
Common conditions associated with Atelectasis:
- Multiple myeloma: 876 reports
- Osteoporosis: 840 reports
- High blood pressure: 745 reports
- Pain: 670 reports
- Rheumatoid arthritis: 579 reports
- Depression: 566 reports
All the conditions that are associated with Atelectasis:
- Atelectasis (1,552 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fosamax and Valcyte drug interaction - 8 seconds ago
- Diltiazem Hydrochloride and Aortic Thrombosis - 35 seconds ago
- Hydrocodone Bitartrate And Acetaminophen and Respiratory Distress - 37 seconds ago
- Ditropan and Fainting - 37 seconds ago
- Gabapentin and Somavert drug interaction - 37 seconds ago
- Sertraline and Dactylitis - 49 seconds ago
- Viibryd and Heart Attack - a minute ago
- Flecainide Acetate and Paranoia - a minute ago
- Cosopt and Sinus Pain - a minute ago
- Allergic Rhinitis and drugs of ingredients of eszopiclone - a minute ago